Nuvation Bio earnings beat by $0.02, revenue was in line with estimates
Nuvation Bio earnings beat by $0.02, revenue was in line with estimates
Nuvation Bio (NYSE: NUVB) reported first-quarter EPS of $-0.100, $0.02
Nuvation Bio (NYSE: NUVB) reported first-quarter EPS of $-0.100, $0.02
better than the analyst estimate of $-0.121. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
better than the analyst estimate of $-0.121. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Nuvation Bio's stock price closed at $1.660. It is down -6.210% in the last 3 months and down -69.260% in the last 12 months.
Nuvation Bio's stock price closed at $1.660. It is down -6.210% in the last 3 months and down -69.260% in the last 12 months.
Nuvation Bio saw 1 positive EPS revision and 0 negative EPS revisions in the last 90 days.
Nuvation Bio saw 1 positive EPS revision and 0 negative EPS revisions in the last 90 days.
See Nuvation Bio's stock price’s past reactions to earnings here.
See Nuvation Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Nuvation Bio's Financial Health score is "performance".
According to InvestingPro, Nuvation Bio's Financial Health score is "performance".
Learn more